Karius

Karius is a biotechnology company headquartered in Redwood City, California. With a team of 153 employees, the company has achieved a revenue of $50 million. Karius specializes in infectious disease diagnostics. Their flagship product, the Karius Test, utilizes genomics and artificial intelligence to analyze a patient's blood sample for the presence of microorganisms. This comprehensive microbial mapping allows clinicians to make informed and timely treatment decisions, addressing a wide range of infections. The Karius Test offers a unique approach to infectious disease diagnosis by providing a detailed understanding of the patient's microbiome directly from a blood sample. This non-invasive method eliminates the need for multiple cultures or invasive procedures, streamlining the diagnostic process and potentially improving patient outcomes. For more information about Karius and their innovative diagnostic solutions, visit kariusdx.com.